Convenient and Reliable Analysis of Antibody Drug Conjugates
Applications | 2021 | Agilent TechnologiesInstrumentation
HPLC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsbrentuximab, vedotin, isopropanol, hic, ternary, dar, species, antibody, bio, organic, drug, buffers, solvent, salt, adcs, sst, biocompatible, avoid, five, prime, area, modifier, drugconjugate, retention, pump, potential, outstandingly, antibodies, maleimide, monoclonal, mab, linked, hydrophobic, stainless, high, gradient, steel, heptahydrate, completely, sulfhydryl, rsd, peak, distribution, allowed, groups, mau, challenging, were, here, characterization
Similar PDF
High Salt—High Reproducibility - Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System
2020|Agilent Technologies|Applications
Application Note Biopharma High Salt—High Reproducibility Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System Response (mAU) ×101 D2 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2…
Key words
dar, darhic, hicbrentuximab, brentuximabvedotin, vedotinantibody, antibodydrug, drugsubtraction, subtractionbiocompatible, biocompatiblearea, areaadc, adcsalt, saltmolecules, moleculesmau, mauprecision, precisionspecies
Analysis of Cysteine-Linked Antibody Drug Conjugates
2017|Agilent Technologies|Applications
Analysis of Cysteine-Linked Antibody Drug Conjugates Using Hydrophobic Interaction Chromatography on the Agilent 1260 Infinity II Bio-inert LC Application Note Biologics and Biosimilars Author Abstract Sonja Schneider Hydrophobic interaction chromatography (HIC) is frequently used for the Agilent Technologies, Inc. determination…
Key words
brentuximab, brentuximabvedotin, vedotindar, darhic, hicdrug, drugantibody, antibodyhydrophobic, hydrophobicmmae, mmaeadcs, adcsadc, adctige, tigeinteraction, interactionmab, mablinked, linkedtrastuzumab
High-Performance Biopharma Analysis - Application compendium
2021|Agilent Technologies|Guides
Agilent InfinityLab Bio LC Solutions High-Performance Biopharma Analysis Application compendium 2 Overcome Analytical Challenges in Biopharma The growing complexity of biopharma analysis calls for innovation that delivers excellence across the biopharmaceutical workflow. The Agilent InfinityLab Bio LC Solutions comprise a…
Key words
retention, retentionbio, biogradient, gradientmin, mintime, timenistmab, nistmabmau, mauresponse, responsepeptide, peptidemapping, mappingcharge, chargeagilent, agilentmab, mabrsd, rsdantibody
Fraction Analysis of Cysteine‑Linked Antibody-Drug Conjugates Using Hydrophobic Interaction Chromatography
2017|Agilent Technologies|Applications
Application Note Biologics & Biosimilars Fraction Analysis of Cysteine‑Linked Antibody-Drug Conjugates Using Hydrophobic Interaction Chromatography Agilent 1260 Infinity II Bio-Inert System mAU 700 600 500 400 300 200 100 0 5.0 Author Sonja Schneider Agilent Technologies, Inc Waldbronn, Germany 7.5…
Key words
fraction, fractionhic, hicbrentuximab, brentuximabmau, mauvedotin, vedotincollection, collectionfractionation, fractionationcollector, collectorfractions, fractionshydrophobic, hydrophobicantibody, antibodymin, minconjugates, conjugatescysteine, cysteinedrug